# Clopidogrel bisulfate

NDC: 63739-178
Generic name: Clopidogrel bisulfate
Labeler / Manufacturer: McKesson Corporation dba SKY Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220818
Marketing ended: 20270731
FDA application: ANDA091023

## Active ingredients

- CLOPIDOGREL BISULFATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63739-178"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63739-178
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=823c5dd0-f4e6-9b45-54de-a609caa8fa90